vitiligo
VITILIGO
Vitiligo is an acquired, often familial, melanocytopenic disorder that produces focal depigmentation of the skin.
About half of the patients has onset of lesion before the age of 20.
It is a progressive disease wherein spontaneous repigmentation may occur within 6 months.
Precipitating factors include emotional stress, sunburn, chemical exposure, skin trauma, inflammation, irritation or rash that may precede the lesions by 2-3 months.
Lesions are white-colored macules or patches with well-defined borders and otherwise normal skin surface.

Follow Up

Nonsegmental Vitiligo

  • NSV patients on narrow band UVB therapy should be reassessed on the 3rd & 6th mth of therapy
  • If still w/ disease progression after 3 mth of narrow band UVB therapy w/ topical steroid/calcineurin inhibitor therapy, consider switching to systemic corticosteroid therapy
    • After 3-6 mth, consider surgical interventions if disease is stable but w/o repigmentation, or depigmentation therapy if w/o repigmentation & w/ Koebner phenomenon
    • After 9 mth of narrow band UVB treatment, consider surgical interventions if disease is stable but repigmentation stopped

Segmental Vitiligo

  • Reassess patients on topical steroids & calcineurin inhibitors on the 6th mth of therapy
Editor's Recommendations
Most Read Articles
04 Nov 2016
The use of hyaluronic acid (HA) filler has been found safe and effective for treatment of facial lipoatrophy (FLA) associated with human immunodeficiency virus (HIV) disease, according to a study.
07 May 2015
The treatment armamentarium of atopic dermatitis (AD) includes pharmaceuticals like emollients, topical corticosteroids, and topical calcineurin inhibitors. Recently available, medical devices are a newer class of topical, non-steroidal, semi-solid formulation for the treatment of AD and touted to possess emollient, anti-inflammatory, and anti-pruritic properties. To determine the role of medical devices in flare and remission management in AD, a panel of local experts from the field of dermatology, paediatric dermatology, and allergy convened to review the available evidence and highlights of the meeting are reported here.
2 days ago
Hydrochlorothiazide (HCTZ) appears to significantly increase the risks of nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC), a recent study has shown.
01 Jul 2013

Acne is particularly prevalent during adolescence, and some teenagers will face an on-going battle with this common skin condition.